Skip to main content
OpenTrials
Completed

NCT Number: NCT00620841

Gene Polymorphisms in Tacrolimus Drug Interactions

A retrospective analysis of the influence of gene polymorphisms on drug interactions between calcineurin-inhibitors and concomitant drugs in renal transplant patients.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Renal Transplantation

Age range

18 year–75 year

Sex eligibility

All sexes

Study type

Observational

Primary location

University Hospitals Leuven

Leuven, Brabant, B-3000, Belgium

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Treatment with calcineurin-inhibitor
  • Renal transplantation

Exclusion criteria

  • Drug, alcohol addiction

Treatment and study plan

genotyping

Other

Restriction fragment lenght polymorphisms

Primary outcomes

  1. Tacrolimus exposure parameters

    Time frame: weeks

Secondary outcomes

  1. Tacrolimus daily dosing

    Time frame: weeks

Sponsors and collaborators

Lead sponsor

KU Leuven

Other

Collaborators

  • Fund for Scientific Research, Flanders, Belgium

Registry information

Official study title

Gene Polymorphisms in Tacrolimus Drug Interactions in Renal Transplant Patients

Acronym: DDI-TAC

Important dates

Study start
2007
Primary completion
2008
Study completion
2008
First posted
Feb 22, 2008
Registry last updated
Feb 22, 2008

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.